Literature DB >> 18279922

Racial differences in treatment of early-stage prostate cancer.

Kathryn E Richert-Boe1, Sheila Weinmann, Jean A Shapiro, Benjamin A Rybicki, Shelley M Enger, Stephen K Van Den Eeden, Noel S Weiss.   

Abstract

OBJECTIVES: To determine whether differences existed in prostate cancer treatment received by white and African American men at a health maintenance organization where access to medical care is theoretically equal for all members and, if so, to determine the reasons for these differences.
METHODS: We used information from the Kaiser Permanente Northwest Tumor Registry to identify all men diagnosed with local- or regional-stage prostate cancer between 1980 and 2000. We compared the likelihood of treatment with curative intent (TCI) between the two races, adjusting for age, tumor grade, stage, and the presence of comorbid conditions. We reviewed medical records of all 79 African American men and a sample of 158 white men (matched for age, stage, grade, and year of diagnosis) to determine the reasons that men did or did not receive TCI.
RESULTS: Seventy-one percent of African American men and 82% of white men were treated with curative intent (P = 0.01). African American men were not more likely than white men to refuse TCI when it was offered (10.6% versus 8.1%, respectively; P = 0.6). However, urologists offered TCI less often to African American men than to white men (85% versus 91%, respectively; P = 0.02), and this difference could not be explained by differences in age, tumor grade, stage, or presence of comorbid conditions.
CONCLUSIONS: African American men were less likely to receive TCI than white men. Because all of the men were insured, economic factors did not cause this difference. Furthermore, the cause did not seem to be differences in age, tumor grade, stage, or comorbid conditions.

Entities:  

Mesh:

Year:  2008        PMID: 18279922     DOI: 10.1016/j.urology.2007.10.010

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  12 in total

1.  African-American Men with Low-Risk Prostate Cancer: Modern Treatment and Outcome Trends.

Authors:  Augustine C Obirieze; Ambria Moten; Delenya Allen; Chiledum A Ahaghotu
Journal:  J Racial Ethn Health Disparities       Date:  2014-12-16

2.  Racial Differences in Prostate Cancer Treatment: The Role of Socioeconomic Status.

Authors:  Megan Watson; David Grande; Archana Radhakrishnan; Nandita Mitra; Katelyn R Ward; Craig Evan Pollack
Journal:  Ethn Dis       Date:  2017-07-20       Impact factor: 1.847

3.  Racial/ethnic disparities in survival among men diagnosed with prostate cancer in Texas.

Authors:  Arica White; Ann L Coker; Xianglin L Du; Katherine S Eggleston; Melanie Williams
Journal:  Cancer       Date:  2010-11-08       Impact factor: 6.860

4.  Clinical practice guidelines of the French Association for Supportive Care in Cancer and the French Society for Psycho-oncology: refusal of treatment by adults afflicted with cancer.

Authors:  J C Faivre; V Adam; V Block; M Metzger; J Salleron; S Dauchy
Journal:  Support Care Cancer       Date:  2017-06-08       Impact factor: 3.603

5.  Racial/ethnic differences in receipt of pelvic lymph node dissection among men with localized/regional prostate cancer.

Authors:  Matthew H Hayn; Heather Orom; Vickie L Shavers; Martin G Sanda; Mark Glasgow; James L Mohler; Willie Underwood
Journal:  Cancer       Date:  2011-03-31       Impact factor: 6.860

6.  Social and clinical predictors of prostate cancer treatment decisions among men in South Carolina.

Authors:  Sara E Wagner; Bettina F Drake; Keith Elder; James R Hébert
Journal:  Cancer Causes Control       Date:  2011-08-30       Impact factor: 2.506

Review 7.  Disparities at presentation, diagnosis, treatment, and survival in African American men, affected by prostate cancer.

Authors:  Ganna Chornokur; Kyle Dalton; Meghan E Borysova; Nagi B Kumar
Journal:  Prostate       Date:  2010-12-28       Impact factor: 4.104

8.  Racial/Ethnic Disparity in Treatment for Prostate Cancer: Does Cancer Severity Matter?

Authors:  Kelvin A Moses; Heather Orom; Alicia Brasel; Jacquelyne Gaddy; Willie Underwood
Journal:  Urology       Date:  2016-09-22       Impact factor: 2.649

9.  Interplay of race, socioeconomic status, and treatment on survival of patients with prostate cancer.

Authors:  Kendra Schwartz; Isaac J Powell; Willie Underwood; Julie George; Cecilia Yee; Mousumi Banerjee
Journal:  Urology       Date:  2009-12       Impact factor: 2.649

10.  Mitochondrial DNA haplogroups and susceptibility to prostate cancer in a colombian population.

Authors:  D Cano; C F Gomez; N Ospina; J A Cajigas; H Groot; R E Andrade; M M Torres
Journal:  ISRN Oncol       Date:  2014-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.